leadf
logo-loader
viewMTI Wireless Edge Limited

MTI Wireless Edge 'an excellent growth company' with further re-rating potential

Capital Network's Ed Stacey says results for the first quarter of 2019 for MTI Wireless Edge (LON:MWE) showed continued strong progress.

Revenues increased by 16% year-on-year and operating profits 66%. We maintain our full-year (FY) 2019 forecasts, with FY revenue growth of 10% and earnings per share (EPS) growth 27.8%.

Quick facts: MTI Wireless Edge Limited

Price: 84.96 GBX

AIM:MWE
Market: AIM
Market Cap: £75.22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

PharmaDrug pursuing Orphan Drug Designation with FDA to use DMT in kidney...

PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) CEO Daniel Cohen tells Proactive it has filed an application with the FDA to receive an orphan drug designation for the use of DMT in preventing kidney injuries in patients undergoing kidney transplants. Cohen says the group aims to unlock the potential...

13 hours, 48 minutes ago

2 min read